GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
You don't have sufficient rights on this wiki to edit tables. Perhaps you need to log in. Changes you make in the Table editor will not be saved back to the wiki
Ramonet, D, Podhajska, A, Stafa, K, Sonnay, S, Trancikova, A, Tsika, E, Pletnikova, O, Troncoso, JC, Glauser, L and Moore, DJ (2012) PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity. Hum. Mol. Genet. 21:1725-43
Mutations in the ATP13A2 gene (PARK9, OMIM 610513) cause autosomal recessive, juvenile-onset Kufor-Rakeb syndrome and early-onset parkinsonism. ATP13A2 is an uncharacterized protein belonging to the P(5)-type ATPase subfamily that is predicted to regulate the membrane transport of cations. The physiological function of ATP13A2 in the mammalian brain is poorly understood. Here, we demonstrate that ATP13A2 is localized to intracellular acidic vesicular compartments in cultured neurons. In the human brain, ATP13A2 is localized to pyramidal neurons within the cerebral cortex and dopaminergic neurons of the substantia nigra. ATP13A2 protein levels are increased in nigral dopaminergic and cortical pyramidal neurons of Parkinson's disease brains compared with normal control brains. ATP13A2 levels are increased in cortical neurons bearing Lewy bodies (LBs) compared with neurons without LBs. Using short hairpin RNA-mediated silencing or overexpression to explore the function of ATP13A2, we find that modulating the expression of ATP13A2 reduces the neurite outgrowth of cultured midbrain dopaminergic neurons. We also find that silencing of ATP13A2 expression in cortical neurons alters the kinetics of intracellular pH in response to cadmium exposure. Furthermore, modulation of ATP13A2 expression leads to reduced intracellular calcium levels in cortical neurons. Finally, we demonstrate that silencing of ATP13A2 expression induces mitochondrial fragmentation in neurons. Oppositely, overexpression of ATP13A2 delays cadmium-induced mitochondrial fragmentation in neurons consistent with a neuroprotective effect. Collectively, this study reveals a number of intriguing neuronal phenotypes due to the loss- or gain-of-function of ATP13A2 that support a role for this protein in regulating intracellular cation homeostasis and neuronal integrity.
Adenosine Triphosphatases/immunology; Adenosine Triphosphatases/metabolism; Animals; Autophagy; Brain/metabolism; Brain/pathology; Calcium/metabolism; Cells, Cultured; Cytoplasmic Vesicles/metabolism; Dopaminergic Neurons/metabolism; Dopaminergic Neurons/physiology; Humans; Hydrogen-Ion Concentration; Lewy Bodies/ultrastructure; Membrane Proteins/immunology; Membrane Proteins/metabolism; Mice; Mitochondria/ultrastructure; Neurites/physiology; Neurites/ultrastructure; Neurons/metabolism; Neurons/physiology; Neurons/ultrastructure; Parkinson Disease/metabolism; Parkinson Disease/pathology; Proton-Translocating ATPases/immunology; Proton-Translocating ATPases/metabolism; Pyramidal Cells/metabolism; RNA Interference; Rats; Substantia Nigra/metabolism; Substantia Nigra/pathology